These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10536419

  • 21. Detection of serum autoantibodies to tumor suppressor gene p53 with a new enzyme-linked immunosorbent assay in patients with ovarian cancer.
    Marx D, Frey M, Zentgraf H, Adelssen G, Schauer A, Kuhn W, Meden H.
    Cancer Detect Prev; 2001; 25(2):117-22. PubMed ID: 11341346
    [Abstract] [Full Text] [Related]

  • 22. [The plasma levels and diagnostic utility of stem cell factor and macrophage--colony stimulating factor in endometrial cancer patients].
    Lawicki S, Bedkowska E, Gacuta-Szumarska E, Czygier M, Szmitkowski M.
    Przegl Lek; 2007; 64(12):987-90. PubMed ID: 18595499
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer.
    Kuropkat C, Duenne AA, Herz U, Renz H, Werner JA.
    Neoplasma; 2004; 51(5):375-8. PubMed ID: 15640942
    [Abstract] [Full Text] [Related]

  • 26. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G, Malamou-Mitsi V, Briasoulis E, Damala K, Vassou A, Vartholomatos G, Kolaitis N, Pavlidis N.
    Cancer; 2004 Oct 15; 101(8):1767-75. PubMed ID: 15386335
    [Abstract] [Full Text] [Related]

  • 27. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R, Stephens RW, Brünner N, Christensen IJ, Nielsen HJ, Heilmann L, von Tempelhoff GF.
    Gynecol Oncol; 2001 Sep 15; 82(3):523-31. PubMed ID: 11520150
    [Abstract] [Full Text] [Related]

  • 28. Increased levels of serum macrophage colony-stimulating factor before the onset of preeclampsia.
    Hayashi M, Ohkura T, Inaba N.
    Horm Metab Res; 2003 Oct 15; 35(10):588-92. PubMed ID: 14605992
    [Abstract] [Full Text] [Related]

  • 29. Macrophage migration inhibitory factor expression in ovarian cancer.
    Agarwal R, Whang DH, Alvero AB, Visintin I, Lai Y, Segal EA, Schwartz P, Ward D, Rutherford T, Mor G.
    Am J Obstet Gynecol; 2007 Apr 15; 196(4):348.e1-5. PubMed ID: 17403417
    [Abstract] [Full Text] [Related]

  • 30. Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection.
    Le Meur Y, Leprivey-Lorgeot V, Mons S, José M, Dantal J, Lemauff B, Aldigier JC, Leroux-Robert C, Praloran V.
    Nephrol Dial Transplant; 2004 Jul 15; 19(7):1862-5. PubMed ID: 15150350
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of histologic type on levels of macrophage colony-stimulating factor in liquid contents of benign ovarian tumors.
    Hayashi M, Shibazaki M, Sohma R, Inaba N.
    Am J Med Sci; 2006 Oct 15; 332(4):181-5. PubMed ID: 17031243
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
    Pinke DE, Kalloger SE, Francetic T, Huntsman DG, Lee JM.
    Gynecol Oncol; 2008 Mar 15; 108(3):561-8. PubMed ID: 18164751
    [Abstract] [Full Text] [Related]

  • 37. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
    Xu KF, Chen Y, Guo ZJ, Zhu YJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec 15; 27(12):824-8. PubMed ID: 15730782
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T, Nakahama K, Asakawa Y, Maemura T, Tanaka M, Takeda S, Morita M, Morita I.
    Gynecol Endocrinol; 2009 Feb 15; 25(2):104-9. PubMed ID: 19253105
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.